Shanghai Sanyou Medical Co., Ltd (SHA:688085)
17.69
+0.19 (1.09%)
Apr 30, 2026, 3:00 PM CST
Shanghai Sanyou Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 39.12 | 44.89 | 11.47 | 95.58 | 190.82 | 186.37 |
Depreciation & Amortization | 38.28 | 38.28 | 36.91 | 30.03 | 18.99 | 15.49 |
Other Amortization | 21.41 | 21.41 | 24.51 | 24.35 | 15.23 | 12.65 |
Loss (Gain) From Sale of Assets | 0.07 | 0.07 | -6.43 | 0.05 | 0.06 | -0.04 |
Asset Writedown & Restructuring Costs | 32.14 | 32.14 | 10.22 | - | - | 2.83 |
Loss (Gain) From Sale of Investments | 3.55 | 3.55 | -5.68 | 6.89 | -41.59 | -53.77 |
Provision & Write-off of Bad Debts | - | - | 1.05 | -8.76 | 2.79 | - |
Other Operating Activities | -1.89 | -0.46 | 18.56 | 29.58 | 20.56 | 9.11 |
Change in Accounts Receivable | -12.91 | -12.91 | 2.06 | 214.68 | -39.32 | -70.1 |
Change in Inventory | -61.1 | -61.1 | -68.15 | -73.57 | -55.03 | -40.6 |
Change in Accounts Payable | -5.79 | -5.79 | -25.46 | -65.73 | 39.84 | 75.88 |
Change in Other Net Operating Assets | 12.05 | 12.05 | 7.87 | -0.23 | 0.77 | 4.04 |
Operating Cash Flow | 60.8 | 67.99 | 10.96 | 267.43 | 155.97 | 144.92 |
Operating Cash Flow Growth | 37.80% | 520.07% | -95.90% | 71.46% | 7.63% | 86.94% |
Capital Expenditures | -22.77 | -28.91 | -37.44 | -25.94 | -138.2 | -91.66 |
Sale of Property, Plant & Equipment | 0.53 | 0.53 | 5.42 | 0.15 | - | 0.37 |
Cash Acquisitions | - | - | - | -30.38 | -0.97 | -268.48 |
Investment in Securities | -36.25 | -131.47 | -204.34 | 123.88 | -25.86 | 356 |
Other Investing Activities | 5.72 | 2.45 | 2.76 | 1.08 | 8.88 | 16.14 |
Investing Cash Flow | -52.77 | -157.4 | -233.59 | 68.8 | -156.15 | 12.36 |
Long-Term Debt Issued | - | 19.71 | 45.14 | - | - | - |
Long-Term Debt Repaid | - | -25.04 | -51.94 | -3.55 | -4.52 | -1.46 |
Net Debt Issued (Repaid) | -3.24 | -5.33 | -6.8 | -3.55 | -4.52 | -1.46 |
Issuance of Common Stock | - | 205.3 | - | - | - | - |
Common Dividends Paid | -2 | -2.14 | -22.65 | -19.2 | -37.37 | -35.86 |
Other Financing Activities | 22.69 | -179.22 | 1.28 | - | - | - |
Financing Cash Flow | 17.45 | 18.61 | -28.17 | -22.75 | -41.9 | -37.32 |
Foreign Exchange Rate Adjustments | 1.44 | 3.36 | -0.47 | 0.44 | 0.19 | -0.1 |
Net Cash Flow | 26.92 | -67.44 | -251.26 | 313.92 | -41.88 | 119.85 |
Free Cash Flow | 38.03 | 39.08 | -26.47 | 241.5 | 17.78 | 53.26 |
Free Cash Flow Growth | 190.29% | - | - | 1258.46% | -66.62% | 13.15% |
Free Cash Flow Margin | 6.92% | 7.20% | -5.84% | 52.45% | 2.74% | 8.98% |
Free Cash Flow Per Share | 0.11 | 0.12 | -0.10 | 0.80 | 0.06 | 0.18 |
Cash Income Tax Paid | 44.54 | 41.83 | 19.75 | 71.76 | 119.5 | 69.84 |
Levered Free Cash Flow | -40.22 | -173.89 | -34.28 | 228.66 | -54.62 | 41.23 |
Unlevered Free Cash Flow | -40.22 | -173.89 | -33.55 | 228.83 | -54.49 | 41.33 |
Change in Working Capital | -71.89 | -71.89 | -79.63 | 89.71 | -50.88 | -34.95 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.